Literature DB >> 30011095

IL-1β induces increased tight junction permeability in bovine mammary epithelial cells via the IL-1β-ERK1/2-MLCK axis upon blood-milk barrier damage.

Tong Xu1, Zhijian Dong2, Xixi Wang1, Shaopei Qi1, Xueru Li1, Rui Cheng1, Xu Liu1,3, Yong Zhang1,3, Ming-Qing Gao1,3.   

Abstract

Bovine mastitis occurs frequently in dairy cows and is often caused by various aetiological organisms, for example, Escherichia coli. Lipopolysaccharide (LPS) is a key virulence factor of E. coli. In this study, we stimulated bovine mammary epithelial cells (BMECs) with LPS to investigate the global transcriptional response and identify specific proinflammatory factors that play important roles in blood-milk barrier damage during mastitis caused by E. coli. By performing RNA-seq, we identified a large number of significantly differentially expressed genes (DEGs) between the LPS-treated BMECs and the control cells. Among the DEGs, interleukin-1β (IL-1β) was selected because its messenger RNA expression was induced by LPS and its enrichment is involved in multiple inflammatory signal pathways, and its roles in blood-milk barrier damage during the process of mastitis were investigated. Exogenous IL-1β treatment damaged the integrity of the blood-milk barrier, as indicated by the increased BMEC tight junction (TJ) permeability and confirmed by in vitro and in vivo experiments. Furthermore, the IL-1β-induced increase in the BMEC TJ permeability was mediated by the IL-1β-ERK1/2-MLCK axis pathway. Our data provide insights into the functions of IL-1β in blood-milk barrier damage caused by mastitis in dairy cows.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  blood-milk barrier; bovine mastitis; interleukin-1β; myosin light chain kinase; tight junction

Mesh:

Substances:

Year:  2018        PMID: 30011095     DOI: 10.1002/jcb.27160

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Non-canonical Inflammasome-Mediated IL-1β Production by Primary Endometrial Epithelial and Stromal Fibroblast Cells Is NLRP3 and Caspase-4 Dependent.

Authors:  Paul Kelly; Kieran G Meade; Cliona O'Farrelly
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

2.  LRRC75A antisense lncRNA1 knockout attenuates inflammatory responses of bovine mammary epithelial cells.

Authors:  Xixi Wang; Hao Wang; Ruiqi Zhang; Dan Li; Ming-Qing Gao
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

Review 3.  IL-1β and the Intestinal Epithelial Tight Junction Barrier.

Authors:  Lauren W Kaminsky; Rana Al-Sadi; Thomas Y Ma
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

4.  Selenium and Taurine Combination Is Better Than Alone in Protecting Lipopolysaccharide-Induced Mammary Inflammatory Lesions via Activating PI3K/Akt/mTOR Signaling Pathway by Scavenging Intracellular ROS.

Authors:  Dandan Liu; Jiashan Lin; Wenmiao He; Kehe Huang
Journal:  Oxid Med Cell Longev       Date:  2021-12-13       Impact factor: 7.310

5.  Preliminary Study on Gene Regulation and its Pathways in Chinese Holstein Cows with Clinical Mastitis Caused by Staphylococcus Aureus.

Authors:  Wenjia Wang; Rongling Li; Tingzhu Ye; Xinxin Zhang; Chao Chen; Ai-Xin Liang; Li-Guo Yang
Journal:  J Vet Res       Date:  2022-05-05       Impact factor: 2.058

6.  The Assessment on Synergistic Activity of Ebselen and Silver Ion Against Yersinia pseudotuberculosis.

Authors:  Chuanjiang Dong; Wei Chen; Lili Zou; Binbin Liu; Kaihong Deng; Dingrui Guo; Peng Wang; Hao Chen; Helen Wang; Jun Wang
Journal:  Front Microbiol       Date:  2022-07-25       Impact factor: 6.064

7.  Total flavonoids of Abrus cantoniensis inhibit CD14/TLR4/NF-κB/MAPK pathway expression and improve gut microbiota disorders to reduce lipopolysaccharide-induced mastitis in mice.

Authors:  Wen-Jing Sun; En-Yun Wu; Ge-Yin Zhang; Bai-Chang Xu; Xiao-Gang Chen; Kai-Yuan Hao; Ying Wang; Ling-Zhi He; Qi-Zhuang Lv
Journal:  Front Microbiol       Date:  2022-08-24       Impact factor: 6.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.